glp-1 gip therapy alternatives 2025 GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous production and L-cell differentiation | Diabetology & Metabolic Syndrome GLP Weight Loss Medications |

Twentieth century advances in peptide biochemistry and protein sequencing enabled John Brown to purify the first incretin, named GIP, in the 1970s

Successful treatment of binge eating disorder with the GLP-1 agonist semaglutide: a retrospective cohort study

Conflict of interest statement Within the last 36 months, FK has served on scientific advisory panels and/or been part of speaker's bureaus for, served as a consultant to and/or received research support from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Gubra, MedImmune, MSD/Merck, Mundipharma, Norgine, Novo Nordisk, Sanofi and Zealand Pharma

But from the $33 billion Americans spend each year on weight loss products and services to government efforts like first lady Michelle Obamas Lets Move campaign or Make America Healthy Again, little has worked